Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application.

Karagiannis SN, Josephs DH, Karagiannis P, Gilbert AE, Saul L, Rudman SM, Dodev T, Koers A, Blower PJ, Corrigan C, Beavil AJ, Spicer JF, Nestle FO, Gould HJ.

Cancer Immunol Immunother. 2012 Sep;61(9):1547-64. doi: 10.1007/s00262-011-1162-8. Epub 2011 Dec 3. Review.

PMID:
22139135
[PubMed - indexed for MEDLINE]
2.

Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity.

Rudman SM, Josephs DH, Cambrook H, Karagiannis P, Gilbert AE, Dodev T, Hunt J, Koers A, Montes A, Taams L, Canevari S, Figini M, Blower PJ, Beavil AJ, Nicodemus CF, Corrigan C, Kaye SB, Nestle FO, Gould HJ, Spicer JF, Karagiannis SN.

Clin Exp Allergy. 2011 Oct;41(10):1400-13. doi: 10.1111/j.1365-2222.2011.03770.x. Epub 2011 May 16.

PMID:
21569129
[PubMed - indexed for MEDLINE]
3.

Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells.

Karagiannis P, Singer J, Hunt J, Gan SK, Rudman SM, Mechtcheriakova D, Knittelfelder R, Daniels TR, Hobson PS, Beavil AJ, Spicer J, Nestle FO, Penichet ML, Gould HJ, Jensen-Jarolim E, Karagiannis SN.

Cancer Immunol Immunother. 2009 Jun;58(6):915-30. doi: 10.1007/s00262-008-0607-1. Epub 2008 Oct 22.

PMID:
18941743
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

IgE-antibody-dependent immunotherapy of solid tumors: cytotoxic and phagocytic mechanisms of eradication of ovarian cancer cells.

Karagiannis SN, Bracher MG, Hunt J, McCloskey N, Beavil RL, Beavil AJ, Fear DJ, Thompson RG, East N, Burke F, Moore RJ, Dombrowicz DD, Balkwill FR, Gould HJ.

J Immunol. 2007 Sep 1;179(5):2832-43.

PMID:
17709497
[PubMed - indexed for MEDLINE]
Free Article
5.

Animal models for IgE-meditated cancer immunotherapy.

Daniels TR, Martínez-Maza O, Penichet ML.

Cancer Immunol Immunother. 2012 Sep;61(9):1535-46. doi: 10.1007/s00262-011-1169-1. Epub 2011 Dec 23. Review.

PMID:
22193986
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

AllergoOncology: the role of IgE-mediated allergy in cancer.

Jensen-Jarolim E, Achatz G, Turner MC, Karagiannis S, Legrand F, Capron M, Penichet ML, Rodríguez JA, Siccardi AG, Vangelista L, Riemer AB, Gould H.

Allergy. 2008 Oct;63(10):1255-66. doi: 10.1111/j.1398-9995.2008.01768.x. Epub 2008 Jul 26. Review.

PMID:
18671772
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

IgE-based immunotherapy of cancer: challenges and chances.

Singer J, Jensen-Jarolim E.

Allergy. 2014 Feb;69(2):137-49. doi: 10.1111/all.12276. Epub 2013 Oct 14. Review.

PMID:
24117861
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Comparison of IgE and IgG antibody-dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma.

Gould HJ, Mackay GA, Karagiannis SN, O'Toole CM, Marsh PJ, Daniel BE, Coney LR, Zurawski VR Jr, Joseph M, Capron M, Gilbert M, Murphy GF, Korngold R.

Eur J Immunol. 1999 Nov;29(11):3527-37.

PMID:
10556807
[PubMed - indexed for MEDLINE]
9.

FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.

Valerius T, Stockmeyer B, van Spriel AB, Graziano RF, van den Herik-Oudijk IE, Repp R, Deo YM, Lund J, Kalden JR, Gramatzki M, van de Winkel JG.

Blood. 1997 Dec 1;90(11):4485-92.

PMID:
9373259
[PubMed - indexed for MEDLINE]
Free Article
10.

Using the allergic immune system to target cancer: activity of IgE antibodies specific for human CD20 and MUC1.

Teo PZ, Utz PJ, Mollick JA.

Cancer Immunol Immunother. 2012 Dec;61(12):2295-309. doi: 10.1007/s00262-012-1299-0. Epub 2012 Jun 13.

PMID:
22692757
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Passive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy.

Flicker S, Linhart B, Wild C, Wiedermann U, Valenta R.

Immunobiology. 2013 Jun;218(6):884-91. doi: 10.1016/j.imbio.2012.10.008. Epub 2012 Oct 26.

PMID:
23182706
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Bispecific antibodies targeting cancer cells.

Peipp M, Valerius T.

Biochem Soc Trans. 2002 Aug;30(4):507-11. Review.

PMID:
12196124
[PubMed - indexed for MEDLINE]
13.

Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cells.

Karagiannis SN, Wang Q, East N, Burke F, Riffard S, Bracher MG, Thompson RG, Durham SR, Schwartz LB, Balkwill FR, Gould HJ.

Eur J Immunol. 2003 Apr;33(4):1030-40.

PMID:
12672069
[PubMed - indexed for MEDLINE]
14.

IgE immunotherapy: a novel concept with promise for the treatment of cancer.

Josephs DH, Spicer JF, Karagiannis P, Gould HJ, Karagiannis SN.

MAbs. 2014 Jan-Feb;6(1):54-72. doi: 10.4161/mabs.27029.

PMID:
24423620
[PubMed - in process]
15.

Recombinant IgE antibody engineering to target EGFR.

Spillner E, Plum M, Blank S, Miehe M, Singer J, Braren I.

Cancer Immunol Immunother. 2012 Sep;61(9):1565-73. doi: 10.1007/s00262-012-1287-4. Epub 2012 Jun 7. Review.

PMID:
22674055
[PubMed - indexed for MEDLINE]
16.

IgE class-restricted tolerance induced by neonatal administration of soluble or cell-bound IgE. Cellular mechanisms.

Chen SS, Liu FT, Katz DH.

J Exp Med. 1984 Oct 1;160(4):953-70.

PMID:
6237166
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells.

Karagiannis SN, Bracher MG, Beavil RL, Beavil AJ, Hunt J, McCloskey N, Thompson RG, East N, Burke F, Sutton BJ, Dombrowicz D, Balkwill FR, Gould HJ.

Cancer Immunol Immunother. 2008 Feb;57(2):247-63. Epub 2007 Jul 27.

PMID:
17657488
[PubMed - indexed for MEDLINE]
19.

64Cu-DOTA hu4D5v8 (scFv-CH2-CH3)2.

Cheng KT.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2006 Apr 11 [updated 2008 Apr 03].

PMID:
20641754
[PubMed]
Books & Documents
20.

Developing antibodies for targeting immunoglobulin and membrane-bound immunoglobulin E.

Chang TW.

Allergy Asthma Proc. 2006 Mar-Apr;27(2 Suppl 1):S7-14. Review.

PMID:
16722326
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk